Sahil
Sheth

Washington, DC

2001 K Street, NW
Washington, DC 20006-1047

Practices & Industries

Litigation

Antitrust

Education

J.D., University of Southern California Gould School of Law

B.A., University of California, Berkeley

Bar Admissions

District of Columbia

Sahil Sheth is an associate in the Litigation Department focusing on antitrust matters. Sahil counsels clients on a wide range of antitrust matters, with an emphasis on mergers and acquisitions, joint ventures and investigations by the U.S. Department of Justice, U.S. Federal Trade Commission, state attorneys general and international enforcers. His experience spans a broad range of industries, including technology, healthcare, pharmaceuticals, consumer products, telecommunications and energy.

Sahil’s notable representations include:

  • ForgeRock, a global digital identity leader, in its acquisition by Thoma Bravo, a leading technology private equity firm, with portfolio company Ping that competes against ForgeRock, a transaction valued at approximately $2.3 billion.*
  • Roark Capital Group in connection with its successful acquisition of Subway Restaurants, one of the world’s largest quick service restaurant brands.
  • Endeavor Energy Resources in its $26 billion merger with Diamondback Energy, a Texas-based independent oil and natural gas company.
  • Metronet, the country’s largest and fastest-growing privately owned fiber-to-the-home company, and shareholder Oak Hill Capital on Metronet’s acquisition by a new joint venture between KKR and T-Mobile,
  • IBM in its $6.4 billion acquisition of HashiCorp, a leading hybrid cloud automation vendor.
  • Red Hat in its acquisition of Neural Magic, a pioneer in software and algorithms that accelerate generative AI inference workloads,
  • Secureworks in its $859 million acquisition by Sophos.
  • Envestnet in its $4.5 billion take-private deal with Bain Capital.
  • Rite Aid, in connection with its chapter 11 bankruptcy proceedings and CVS’s acquisition of certain Rite Aid assets. The transaction included CVS’s purchase of the prescription files of 625 Rite Aid pharmacies located in 15 states within CVS’s service areas, as well as CVS’s acquisition and continued operation of 64 Rite Aid stores in Idaho, Oregon, and Washington.
  • 23andMe’s $305 million bankruptcy sale to TTAM Research Institute.
  • ZT Systems in its $4.9 billion acquisition by Advanced Micro Devices.
  • RXO's $1.02 billion acquisition of Coyote Logistics.
  • Inhibrx in the $2.2 billion sale of INBRX-101 to Sanofi.
  • Atrium Health's $75 million acquisition of Harbin Clinic.
  • QXO's $11 billion acquisition of Beacon Roofing Supply.

*Matter worked on prior to joining Paul, Weiss